Silvaco To Accelerate Physics-Based Digital Twins For Semiconductor Design And Manufacturing Using NVIDIA AI And Accelerated Computing

Silvaco announced plans to enhance physics-based digital twins for semiconductor design with NVIDIA AI and accelerated computing, aiming to improve manufacturing accuracy.

Ascentage Pharma Chairman And CEO Dr. Dajun Yang Named To The Medicine Maker Power List 2026

Ascentage Pharma’s Chairman and CEO Dr. Dajun Yang has been recognized in The Medicine Maker Power List 2026, highlighting his influence in the pharmaceutical industry.

Jingdezhen Handicraft Porcelain Industry Sites Added To UNESCO World Heritage List

Jingdezhen’s historic porcelain industry sites have been officially added to UNESCO’s World Heritage List, recognizing their cultural significance and craftsmanship.

Philip R. Lane: Outlook For The Euro Area Economy

ECB economist Philip R. Lane forecasts steady but cautious growth for the euro area, citing inflation and geopolitical risks as key factors.

Maple Street Biscuit Company Sold

Maple Street Biscuit Company has been sold to a new owner, ending its previous ownership. Details of the sale are confirmed but reasons remain unclear.

Union Pacific And CN Announce Agreement To Expand Opportunities

Union Pacific and CN have reached an agreement to expand opportunities for customers, marking a significant development in their ongoing merger efforts.

AMERICAN ELECTRIC POWER CO INC Files 8-K: Executive Change

American Electric Power has filed an 8-K report confirming a key executive change. Details on the leadership update and its implications are provided.

Trump Media Settles Legal Disputes

Trump Media has reached settlements in ongoing legal disputes, ending several lawsuits. Details of the agreements are yet to be disclosed.

KEENON Deploys Humanoids At WAIC 2026

KEENON, a global leader in service robots, unveils humanoid robots at WAIC 2026, marking a significant step in commercial robot deployment.

4DMT Announces Positive 2-Year Data From PRISM Phase 2B Clinical Trial In A Broad Wet AMD Population

4DMT announces favorable 2-year data from its PRISM Phase 2b clinical trial for wet age-related macular degeneration, indicating promising efficacy.